Modernization of Food and Drug Administration's "generally recognized as safe" (GRAS) framework.
2026 · 3rd Quarter (July 1 - Sep 30)
LANXESS CORPORATION
Filed by LANXESS CORPORATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 15, 2026
- Income
- Not reported
- Expenses
- $100,000.00
- Registrant
- LANXESS CORPORATION
- Client
- LANXESS CORPORATION
- Filing UUID
- 1780fd0b-a480-4fec-899a-652fd4f3ff81
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Section 338 tariffs on Canada.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.